Status:

UNKNOWN

Relationship Between Acute Severe Pancreatitis and Mitochondrial DNA

Lead Sponsor:

First People's Hospital of Chenzhou

Conditions:

Severe Acute Pancreatitis

Eligibility:

All Genders

18+ years

Brief Summary

Plasma mtDNA analysis aids in predicting pancreatic necrosis in severe acute pancreatitis patients.After the onset of severe acute pancreatitis, pancreatic necrosis and the content of mtDNA in plasma ...

Detailed Description

Acute pancreatitis is an acute inflammatory disease of the pancreas characterized by the sudden onset of abdominal pain, elevated serum amylase, and edema or necrosis of the pancreas. The clinical cou...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of severe acute pancreatitis
  • Admission time less than two days

Exclusion

  • Malignant Tumor
  • Positive confirmed pregnancy or urinary pregnancy test
  • Acute liver failure
  • Immunosuppressive state
  • Hormone use
  • Transplantation
  • Death within seven days
  • Blood transfusion over 1000ml in seven days
  • Missing Visits
  • Incomplete information
  • Family Requirements

Key Trial Info

Start Date :

July 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04079777

Start Date

July 1 2018

End Date

June 1 2020

Last Update

September 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Hospital of Chenzhou

Chenzhou, Hunan, China, 450003